Gerdau SA (NYSE:GGB) has been given a “BBB-” credit rating by analysts at Morningstar. The investment research firm’s “BBB-” rating suggests that the company is a moderate default risk. They also gave their stock a three star rating. Gerdau S.A. (NYSE:GGB) in last trading activity moved down -1.71% to close at $4.03. Company weekly performance is -7.99% while its quarterly performance stands at -28.80%. Gerdau S.A. (NYSE:GGB) is -50.85% away from its 52 week high.
Barrick Gold Corporation (NYSE:ABX) said Tuesday that it has appointed Shaun Usmar as Senior Executive Vice President and Chief Financial Officer Designate. Barrick Gold Corporation (NYSE:ABX) in last trading activity increased 6.58% to close at $13.29. Company weekly performance is 14.18% while its quarterly performance stands at -28.82%. Barrick Gold Corporation (NYSE:ABX) is -37.54% away from its 52 week high.
On Nov. 4, Gyrodyne Co. of America Inc. (NASDAQ:GYRO) announced that its board of directors has voted to postpone the special meeting of shareholders until the first half of 2015 at which shareholders will be asked to authorize the previously announced merger of Gyrodyne and Gyrodyne Special Distribution, LLC into Gyrodyne, LLC. With approximately 45% of the outstanding shares voted thus far by delivery of proxy cards, approximately 97% of such shares have been voted in favor of the merger. On last trading day Gyrodyne Co. of America Inc. (NASDAQ:GYRO) moved down -6.04% to close at $4.20. Its volatility for the week is 4.81% while volatility for the month is 2.78%. GYRO’s sales growth for past 5 years was 8.00% and its EPS growth for past 5 years was 91.70%. Gyrodyne Co. of America Inc. (NASDAQ:GYRO) monthly performance is -8.69%.
On Nov 04, Bloomin’ Brands Inc. (NASDAQ:BLMN) reported Q3 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion. Bloomin’ Brands, Inc. (NASDAQ:BLMN) has 7.69% insider ownership while its institutional ownership stands at 99.20%. In last trading activity company’s stock closed at $21.77.
Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), announced that David P. Luci, President & Chief Executive Officer, will present a corporate overview at the Oppenheimer 25th Annual Healthcare Conference in New York City, on Wednesday, December 10, 2014 at 1:00 p.m. Eastern Time. On Tuesday shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) closed at $10.25. Company’s EPS growth for next 5 years is recorded as 40.00%.